These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17537555)

  • 1. Production of clinical-grade plasmid DNA for human Phase I clinical trials and large animal clinical studies.
    Przybylowski M; Bartido S; Borquez-Ojeda O; Sadelain M; Rivière I
    Vaccine; 2007 Jun; 25(27):5013-24. PubMed ID: 17537555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GMP production of pDERMATT for vaccination against melanoma in a phase I clinical trial.
    Quaak SG; van den Berg JH; Toebes M; Schumacher TN; Haanen JB; Beijnen JH; Nuijen B
    Eur J Pharm Biopharm; 2008 Oct; 70(2):429-38. PubMed ID: 18606527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.
    Urieto JO; Liu T; Black JH; Cohen KA; Hall PD; Willingham MC; Pennell LK; Hogge DE; Kreitman RJ; Frankel AE
    Protein Expr Purif; 2004 Jan; 33(1):123-33. PubMed ID: 14680969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of pharmaceutical-grade plasmids at high concentration and high supercoiled percentage.
    Cai Y; Rodriguez S; Rameswaran R; Draghia-Akli R; Juba RJ; Hebel H
    Vaccine; 2010 Feb; 28(8):2046-52. PubMed ID: 19896448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of plasmid DNA for human gene therapy using modified alkaline cell lysis and expanded bed anion exchange chromatography.
    Varley DL; Hitchcock AG; Weiss AM; Horler WA; Cowell R; Peddie L; Sharpe GS; Thatcher DR; Hanak JA
    Bioseparation; 1999; 8(1-5):209-17. PubMed ID: 10734573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-scale production of endotoxin-free plasmids for transient expression in mammalian cell culture.
    Rozkov A; Larsson B; Gillström S; Björnestedt R; Schmidt SR
    Biotechnol Bioeng; 2008 Feb; 99(3):557-66. PubMed ID: 17680665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmid DNA purification.
    Stadler J; Lemmens R; Nyhammar T
    J Gene Med; 2004 Feb; 6 Suppl 1():S54-66. PubMed ID: 14978751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of plasmid DNA in industrial quantities according to cGMP guidelines.
    Schorr J; Moritz P; Breul A; Scheef M
    Methods Mol Med; 2006; 127():339-50. PubMed ID: 16988464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of pharmaceutical-grade plasmid DNA by anion-exchange chromatography in an RNase-free process.
    Eon-Duval A; Burke G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 May; 804(2):327-35. PubMed ID: 15081927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved downstream process for the production of plasmid DNA for gene therapy.
    Urthaler J; Buchinger W; Necina R
    Acta Biochim Pol; 2005; 52(3):703-11. PubMed ID: 16175245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GMP production and characterization of the bivalent anti-human T cell immunotoxin, A-dmDT390-bisFv(UCHT1) for phase I/II clinical trials.
    Woo JH; Liu JS; Kang SH; Singh R; Park SK; Su Y; Ortiz J; Neville DM; Willingham MC; Frankel AE
    Protein Expr Purif; 2008 Mar; 58(1):1-11. PubMed ID: 18160309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-scale, nonchromatographic purification of plasmid DNA.
    Murphy JC; Winters MA; Sagar SL
    Methods Mol Med; 2006; 127():351-62. PubMed ID: 16988465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of a cystic fibrosis plasmid vector for gene therapy using hydrophobic interaction chromatography.
    Diogo MM; Queiroz JA; Monteiro GA; Martins SA; Ferreira GN; Prazeres DM
    Biotechnol Bioeng; 2000 Jun; 68(5):576-83. PubMed ID: 10797245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposal for a better integration of bacterial lysis into the production of plasmid DNA at large scale.
    O'Mahony K; Freitag R; Hilbrig F; Müller P; Schumacher I
    J Biotechnol; 2005 Sep; 119(2):118-32. PubMed ID: 15993505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A continuous thermal lysis procedure for the large-scale preparation of plasmid DNA.
    Zhu K; Jin H; Ma Y; Ren Z; Xiao C; He Z; Zhang F; Zhu Q; Wang B
    J Biotechnol; 2005 Aug; 118(3):257-64. PubMed ID: 15982772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large scale purification process for recombinant NS1-OspA as a candidate vaccine for Lyme disease.
    Caldwell SR; Varghese J; Puri NK
    Bioseparation; 1996 Apr; 6(2):115-23. PubMed ID: 8818266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of process flow sheets for the purification of supercoiled plasmids for gene therapy applications.
    Ferreira GN; Cabral JM; Prazeres DM
    Biotechnol Prog; 1999; 15(4):725-31. PubMed ID: 10441364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an anion-exchange LC-UV method for the quantification and purity determination of the DNA plasmid pDERMATT.
    Quaak SG; Nuijen B; Haanen JB; Beijnen JH
    J Pharm Biomed Anal; 2009 Feb; 49(2):282-8. PubMed ID: 19111423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated fed-batch fermentation with feed-back controls based on dissolved oxygen (DO) and pH for production of DNA vaccines.
    Chen W; Graham C; Ciccarelli RB
    J Ind Microbiol Biotechnol; 1997 Jan; 18(1):43-8. PubMed ID: 9079287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precipitation by polycation as capture step in purification of plasmid DNA from a clarified lysate.
    Wahlund PO; Gustavsson PE; Izumrudov VA; Larsson PO; Galaev IY
    Biotechnol Bioeng; 2004 Sep; 87(5):675-84. PubMed ID: 15352066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.